ArticleScientific reports2026

Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis.

Zhongping Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.